Pharma Mar, S.A. (BME:PHM)

Pharma Mar Revenue

Pharma Mar had revenue of 46.25M EUR in the quarter ending June 30, 2026, a decrease of -4.36%. This brings the company's total for the last twelve months to 218.64M, up 25.04% year-over-year. In the year 2025, Pharma Mar had annual revenue of 221.39M with 26.61% growth. That makes Pharma Mar the 15,987th largest company in the world by revenue and 89th in Spain.

• Revenue (ttm): 218.64M
• Revenue Growth: +25.04%
• P/S Ratio: 5.40
• Revenue / Employee: 432.96K
• Employees: 505
• Market Cap: 1.21B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Oncology 221.35M 100.0%
• RNA Interference (RNAi) 36.00K 0.0%

By Geography

Chart

• Ireland 100.62M 45.4%
• Others 28.12M 12.7%
• Germany 27.13M 12.3%
• France 24.24M 10.9%
• United States 20.13M 9.1%
• Rest of EU 12.26M 5.5%
• Switzerland 6.42M 2.9%
• Spain 2.48M 1.1%

Fiscal year ended Dec 31, 2025 See the full Pharma Mar breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	221.39M	46.54M	26.61%
Dec 31, 2024	174.86M	16.70M	10.56%
Dec 31, 2023	158.15M	-38.19M	-19.45%
Dec 31, 2022	196.34M	-33.49M	-14.57%
Dec 31, 2021	229.83M	-40.13M	-14.87%
Dec 31, 2020	269.96M	184.14M	214.57%
Dec 31, 2019	85.82M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error